February 14, 2017, New York, NY – The Food and Drug Administration (FDA) has named Suzanne Robotti, founder and president of MedShadow Foundation, to its Drug Safety and Risk Management Advisory Committee as the Consumer Representative. Next month, she will attend her first hearing where a prescription opioid drug will Continue Reading →
June 13, 2016, New York, NY – MedShadow has been recognized with a Spring 2016 Digital Health Awards Silver designation for its website in the Nonprofit category. Winners were announced on June 10th. Formerly known as the Web Health Awards, the Digital Health Awards are held twice each year – Continue Reading →
“There’s a straight line between the overprescribing of opioids, the public’s misconceptions about these drugs and the rapidly rising number of accidental deaths from opioid addiction.”
Online health advocacy source broadens coverage of side effects, risks and benefits of medicine
NEW YORK, NY, April 28th, 2016 – MedShadow Foundation, an online nonprofit that educates consumers on the side effects, risks and benefits of medicine, has announced the appointment of Jonathan Block as Content Editor.
The AVA Digital Awards today announced winners for the 2016 international awards competition. MedShadow Foundation received two gold awards in the nonprofit website and nonprofit video for the web categories.
MedShadow has received a 2015 Digital Health Awards Bronze in the Web-based Digital Health category.
Side effects-focused health advocacy group questions efficacy of research study
December 15, 2015, New York, NY – On December 14th, JAMA Pediatrics published a report on a University of Montreal study that makes a clear correlation between the use of SSRIs (selective serotonin reuptake inhibitors) — a common group Continue Reading →